Tenaya Therapeutics to present MyPEAK-1 trial data June 3

June 2, 2026 4:30 PM

Tenaya Therapeutics Inc. (NASDAQ: TNYA) announced it will report interim data from its MyPEAK-1 Phase 1b/2 trial of TN-201 gene ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found